HomeQuestion
When do you consider re-starting treatment for a patient with relapsed myeloma?
1
1 Answers
Mednet Member
Medical Oncology · Winship Cancer Institute of Emory University
Do you start anti-myeloma therapy when patients have progressive disease (25% increase in paraprotein or new or worsening myeloma bone disease) or clinical relapse (CRAB criteria, hyperviscosity, new plasmacytoma)? The goal is to pull the trigger right before clinical relapse.
How is this done in th...